Novel extended-spectrum beta-lactamase in Shigella sonnei

Emerg Infect Dis. 2007 Apr;13(4):653-4. doi: 10.3201/eid1304.061160.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Azithromycin / therapeutic use
  • Drug Resistance, Bacterial
  • Dysentery, Bacillary / drug therapy
  • Dysentery, Bacillary / microbiology*
  • Haiti
  • Humans
  • Male
  • Microbial Sensitivity Tests
  • Shigella sonnei / drug effects
  • Shigella sonnei / enzymology*
  • Shigella sonnei / isolation & purification
  • Travel
  • beta-Lactamases / classification*
  • beta-Lactamases / genetics*
  • beta-Lactams / pharmacology

Substances

  • Anti-Bacterial Agents
  • beta-Lactams
  • Azithromycin
  • beta-Lactamases